Serum Institute slashes prices of Covishield for states to Rs 300 per dose
Serum Institute slashes prices of Covishield for states to Rs 300 per dose
Doses of its Covid-19 vaccine Covishield will be made available to states at a price of Rs 300 per dose, Serum Institute of India CEO Adar Poonawalla said in a tweet on Wednesday. This is
advertisement
Employees pack boxes containing vials of Covishield at Serum Institute in Pune (Photo Credits: AP)
HIGHLIGHTS
Serum Institute has received orders for 340 million doses from states
Covishield the most affordable Covid-19 vaccine in the market, SII had said
Adar Poonawalla, CEO of Pune-based Serum Institute of India, said Covishield will be made available to states at a price of Rs 300 per dose. SII, which is producing University of Oxford and AstraZeneca s Covid-19 vaccine, had earlier priced the doses at Rs 400 for states.
Serum Institute reduces Covishield price for govt hospitals to Rs 300
The decision was announced by CEO Adar Poonawalla, who said that this reduction of price is a philanthropic gesture on the part of Serum. He added that this price cut will save thousands of crores of state funds as well as save countless lives
BusinessToday.In | April 28, 2021 | Updated 18:32 IST
Covishield price cut to Rs 300 for govt hospitals
Serum Institute of India has decided to reduce the price of its coronavirus vaccine Covishield to Rs 300 from the earlier rate of Rs 400. The decision was announced by CEO Adar Poonawalla, who said that this reduction of price is a philanthropic gesture on the part of Serum. He added that this price cut will save thousands of crores of state funds as well as save countless lives.
Updated:
The major news headlines of the day, and more.
Share Article
AAA
Syringes filled with Covishield lie on an ice box at a primary health centre in Srinagar on April 28, 2021. | Photo Credit:
AP
The major news headlines of the day, and more.
“As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs 400 to Rs 300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives,” Serum Institute CEO Adar Poonawalla tweeted.
As the registration of all citizens above 18 years of age for vaccination against COVID-19 started on the CoWIN portal at 4 p.m. on April 28, many people took to social media to complain about the technical problems they faced trying to register themselves for the third phase of the inoculation drive that is scheduled to begin from May 1.